Transplacental transfer of Remdesivir and GS-441524: An ex vivo perfusion study

被引：1
|
作者：
Louchet, Margaux [1 ]
Ribot, Megane [1 ]
Bouazza, Naim [2 ]
Foissac, Frantz [2 ]
Froelicher, Leo [1 ]
Buth, Victoria [3 ]
Benaboud, Sihem [1 ]
Treluyer, Jean-Marc [1 ,2 ,3 ]
Lui, Gabrielle [1 ,3 ,4 ]
机构：
[1] Hop Cochin, Serv Pharmacol, Paris, France
[2] Hop Tarnier, AP HP, Unite Rech Clin, Paris, France
[3] CIC 1419 Mere Enfant Cochin Necker, Paris, France
[4] Hop Cochin, Serv Pharmacol, 27 Rue Faubourg St Jacques, F-75014 Paris, France
来源：
HEALTH SCIENCE REPORTS | 2023年 / 6卷 / 07期
关键词：
ex vivo cotyledon perfusion; GS-441524; placenta; Remdesivir; transplacental transfer; EXPRESSION; GENE;
D O I：
10.1002/hsr2.1144
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：4
相关论文
共 40 条
  • [1] Remdesivir and GS-441524 Extraction by Ex Vivo Extracorporeal Life Support Circuits
    Imburgia, Carina E.
    Rower, Joseph E.
    Green, Danielle J.
    Mcknite, Autumn M.
    Kelley, Walter E.
    Reilly, Christopher A.
    Watt, Kevin M.
    ASAIO JOURNAL, 2022, 68 (09) : 1204 - 1210
  • [2] Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy
    Schmidt, Julius J.
    Bode-Boeger, Stefanie M.
    Martens-Lobenhoffer, Jens
    Hoeper, Marius M.
    Kielstein, Jan T.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (08): : 1256 - 1257
  • [3] Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity
    Yan, Victoria C.
    Muller, Florian L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)
  • [4] Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment
    Xie, Jiashu
    Wang, Zhengqiang
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (06) : 1607 - 1616
  • [5] Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
    Leegwater, E.
    Moes, D. J. A. R.
    Bosma, L. B. E.
    Ottens, T. H.
    van der Meer, I. M.
    van Nieuwkoop, C.
    Wilms, E. B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
  • [6] Biotransformation and transplacental transfer of the anti-viral remdesivir and predominant metabolite, GS- 441524 in rats
    Yang, Ling
    Lin, I-Hsin
    Lin, Lie-Chwen
    Dalley, Jeffrey W.
    Tsai, Tung-Hu
    EBIOMEDICINE, 2022, 81
  • [7] Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
    Amirian, E. Susan
    Levy, Julie K.
    ONE HEALTH, 2020, 9
  • [8] Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
    Yan, Victoria C.
    Muller, Florian L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (07): : 1361 - 1366
  • [9] Assessing in vitro stability of remdesivir (GS-5734) and conversion to GS-441524 in feline plasma and whole blood
    Coggins, Sally J.
    Kimble, Benjamin
    Malik, Richard
    Thompson, Mary F.
    Norris, Jacqueline M.
    Govendir, Merran
    VETERINARY QUARTERLY, 2024, 44 (01) : 1 - 9
  • [10] Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series
    Nishikawa, Asami
    Ito, Isao
    Yonezawa, Atsushi
    Itohara, Kotaro
    Matsubara, Takeshi
    Sato, Yuki
    Matsumura, Katsuyuki
    Hamada, Satoshi
    Tanabe, Naoya
    Kai, Shinichi
    Imoto, Eishi
    Yoshikawa, Kohei
    Ohtsuru, Shigeru
    Yanagita, Motoko
    Hirai, Toyohiro
    Terada, Tomohiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (04) : 348 - 351
1234